Smart science to improve lives™
Open search Basket 0 View basket

Gain insights from our experts...

Optimizing lipid nanoparticles (LNPs) processing for siRNA delivery by microfluidics system

The success of mRNA vaccines during the COVID-19 pandemic has accelerated the advancement of nucleic acid delivery technologies. In addition to mRNA, interfering RNA offers potential to treat diseases beyond the reach of small molecules. However, therapeutic success hinges on efficient and targeted delivery systems. Lipid nanoparticles (LNPs), especially those produced via microfluidics, have emerged as a leading platform for RNA delivery. delivery. for RNA.  

Join Dr. Qiaobin Hu as he explores LNP formulation for siRNA delivery using a microfluidic flow-focusing system.  

Optimising lipid nanoparticles (LNPs) processing for siRNA delivery by microfluidics system

Croda Pharma Poster cover for Optimising lipid nanoparticles (LNPs) processing for siRNA delivery by microfluidics system
866.3 KB

Explore our poster presentation with Qiaobin Hu

Explore recent blogs:

Mo Pinto, Croda Pharma

Biologics Leader: Mo Pinto

In our latest edition of Biologics Leaders, we speak to Mo Pinto. Keep reading to learn more...
ch toothpaste

Meeting the demand for sulphate-free oral care

Formulators are seeking gentle yet effective surfactants that meet regulatory and consumer expectations. That’s where Adinol™ CT95 comes in...
tina

Spotlight on R&D - Tina Baharlou, Industrial Placement Student

This week we caught up with Tina Baharlou, a current Industrial placement student based at our Head Office labs in the UK. Tina has spent the past year immersed in advanced formulation work focused on...